The Shift Toward Oral Metabolic Health: A New Era for Seniors For years, the conversation around weight management in older adults has been cautious. The fear of muscle loss, the complexity of injectable medications, and a general lack of clinical data specifically targeting the 65+ demographic often left healthcare providers and patients hesitant. However, a … Read more
Ascletis Pharma Presents Promising Data for Novel Obesity Treatments at ADA 2026 Ascletis Pharma Inc. (HKEX: 1672) is set to present compelling preclinical and clinical data at the American Diabetes Association’s (ADA) 2026 Scientific Sessions, taking place June 5–8 in Recent Orleans, Louisiana. The presentations spotlight the company’s innovative pipeline of oral little molecule therapeutics … Read more
The Shift Toward Precision Self-Medication For decades, the pharmacy aisle has been a “one size fits all” experience. You have a headache. you buy paracetamol. You have a cough; you reach for a codeine-based syrup. But the future of over-the-counter (OTC) medicine is moving toward pharmacogenomics—the study of how your genes affect your response to … Read more
The battle over how we treat Alzheimer’s disease has reached a fever pitch. On one side, we have the gold-standard rigor of the Cochrane review, suggesting that clearing amyloid plaques from the brain is like painting a house while the foundation is crumbling—it looks better on a scan, but the structure is still failing. On … Read more
President Donald Trump has nominated Erica Schwartz to serve as the director of the Centers for Disease Control and Prevention (CDC), ending a months-long search for a permanent leader of the agency. Schwartz, who must be confirmed by the Senate, will enter the role as Health and Human Services Secretary Robert F. Kennedy Jr. Manages … Read more
The Rise of ‘Computational Social Listening’: How AI is Uncovering Hidden Drug Side Effects For decades, identifying drug side effects relied heavily on clinical trials and post-market reporting. Now, a new approach is gaining traction: analyzing the vast ocean of patient experiences shared on social media. Researchers at the University of Pennsylvania have pioneered a … Read more
Ecuador’s Bold Move Towards Rabies Elimination: A Blueprint for Global Health Security Ecuador is making significant strides towards becoming only the second country in Latin America to eliminate dog-mediated rabies, following Mexico’s lead. This ambitious goal, guided by the Pan American Health Organization (PAHO), centers on mass dog vaccination, robust epidemiological surveillance, and accessible post-exposure … Read more
The Shifting Landscape of Pharmacy Benefit Managers: Accountability and Transparency on the Horizon For years, concerns have mounted regarding the role of pharmacy benefit managers (PBMs) in the prescription drug supply chain. Accusations of prioritizing profits over patient access and affordability have been widespread. Now, a confluence of Congressional action and Department of Labor (DOL) … Read more
AI Revolutionizes Drug Discovery: Lilly’s $2.75 Billion Bet on Insilico The pharmaceutical industry is undergoing a seismic shift, driven by the rapid advancements in artificial intelligence. This week, Eli Lilly took a massive leap forward, announcing a $2.75 billion deal with Hong Kong-based Insilico Medicine to accelerate the development of AI-discovered drugs. This collaboration isn’t … Read more
Averna Therapeutics Bolsters Leadership: What It Signals for the Future of Gene Therapy Averna Therapeutics’ recent appointments of Robert Mabry as Chief Scientific Officer (CSO) and Richard Morris as Chief Financial Officer (CFO) aren’t just internal shifts; they represent a strategic move within the rapidly evolving landscape of genomic medicine. These hires, announced on March … Read more